Cardiotonic Drugs Flashcards

1
Q

What are cardiotonic drugs/cardiovascular stimulants?

A

Agents that act on the heart and/or vascular tone (BP).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the predominant adrenergic receptors of the heart? What do they cause when stimulated?

A

β1’s; they increase the HR and contractility of the heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the adrenergic receptors in the vasculature? How do they affect the vascular tone when activated?

A
  1. α’s; they cause vasoconstriction (VSM contraction)

2. β2’s are only in skeletal muscle vessels, where they cause vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What happens to the tone of skel m vessels during a fight/flight sympathetic response, given the opposing effects of α1’s and β2’s located there?

A

The increased local demand for O2 in skel m tissue during fight/flight causes the α1-mediated vasoconstriction to be lost and the β2-mediated vasodilatory action predominates.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What causes this loss of α1-mediated vasoconstriction in skel m blood vessels during fight/flight response?

A

Localized control via the release of NO or PG’s, which modulate the effects of α1-R’s and reduce α1-mediated vasoconstriction, leading to the emergence of the β2-vasodilatory effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the 7 cardiovascular stimulant/cardiotonic drugs?

A
  1. Epinephrine (E)
  2. NE
  3. Dopamine (DA)
  4. Dobutamine
  5. Isoproterenol
  6. Phenylephrine
  7. Ephedrine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the mechanism of downstream signaling of α1 and α2 metabotropic receptors?

A

α1→Gq→PLC→DAG and IP3→increase intracellular Ca2+

α2→Gi→inhibits AC→decreased cAMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the mechanism of downstream signaling of the β receptors?

A

β→Gs→stimulation of AC→increased cAMP

occasionaly β2 stimulates cardiac Gi under some conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the downstream signaling mechanism of D1 and D5 receptors? What about D2?

A

D1/5→Gs→stimulation of AC→increased cAMP

D2→Gi→inhibition of AC→reduced cAMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the three classifications of sympathomimetic drugs based on their mechanisms of action?

A
  1. Direct-acting drugs→stimulate the postsynaptic receptor
  2. Indirect-acting drugs→act presynaptically to increase the availability of NE or E
  3. Mixed-acting drugs→direct activation and indirect release of NE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are three mechanisms thru which indirect-acting drugs act presynaptically to increase the availability of NE or E?

A
  1. Releasing or displacing NE from sympathetic nerve terminals
  2. Blocking reuptake/transport of NE into presynaptic sympathetic nerve terminals (e.g. cocaine)
  3. Blocking metabolizing enzymes of catecholamines such as MAO or COMT.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does reserpine work? What effect does it have on the presynaptic availability of nt?

A

Reserpine prevents the packaging of the nt in the presynaptic nerve terminal. So, it depletes NE from sympathetic neurons, so there is no presynaptic NE available.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How would pre-treatment with Reserpine affect the action of a direct-acting drug at the level of the synapse? Why?

A

The response/action of the direct-acting drug is NOT reduced, as this type of drug act directly on the postsynaptic receptors. It may actually increase response, b/c lack of endogenous nt (NE) stimulating the receptor induces compensatory changes that upregulate receptors or enhance the signaling pathway. (this is why you have to taper off BBs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How would pre-treatment with Reserpine affect the action of a indirect-acting drug at the level of the synapse?

A

The response would be ABOLISHED by pre-treatment of reserpine, because there is no presynaptic NE for it to indirectly increase the release of.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How would pre-treatment with Reserpine affect the action of a mixed-acting drug at the level of the synapse? What is this called?

A

The effects are blunted/reduced but not abolished by reserpine, b/c you still get the direct action, but you’ve lost the indirect action. This is a form of TACHYPHYLAXIS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is tachyphylaxis?

A

A fairly rapid loss/reduction of pharmacologic effect. It is progressive, so you’d get less and less effect as you keep repeating the dose. (In contrast, desensitization via endocytosis of GPCRs is a more long-term effect)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Both E and NE are __________?

A

pro-arrhythmogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How do the cardiac effects of E on HR, SV, CO, arrhythmia, and coronary blood flow compare with effects of NE?

A

They are both pro-arrhythrmogenic, and increase SV and coronary blood flow the same.
However, E increases the HR and CO, while NE either has no affect on or decreases these.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Why can E produce this increase in HR, while NE doesn’t?

A

This is b/c of the reflexive relationship b/t BP and SNS stimulation of the heart. NE is predominantly α1-mediated vasoconstriction which increases the BP. Immediately, the vagus (PS) fires off and tries to calm the heart down, so you don’t get the dramatic increase in HR, that you would with E. This is b/c E causes β2-mediated vasodilation of skel m vascular beds.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How do the effects of E and NE on systolic arterial P and diastolic arterial P compare?

A

Both NE and E increase systolic arterial P.
However, E has pretty much no effect on the diastolic arterial P (due to β2 involvement; increases Pulse pressure), while NE produces an increase diastolic P.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the effects of intravenous infusion of NE on PVR, HR, and BP?

A

a) You get potent vasoconstriction (increased PVR), so you get a rise in both systolic and diastolic BP, so the MAP increases, but pulse pressure is not significantly effected.
b) Increased MAP results in results in a reflexive decrease in HR (pulse rate) due to vagal stimulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the effects of IV infusion of E on PVR, HR, and BP?

A

E stimulates the β2’s which vasodilate skel m vessels, so you don’t get the increase in PVR or in diastolic P, and it may even decrease. B/c of that, you dont get the compensatory suppression of the heart function, so HR increases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the effects of IV infusion of isoproterenol on

A

Isoproterenol has no alpha-mediated action at all, only β-mediated. PVR decreases. Pulse pressure increases due to an increase in SBP but a decrease in DBP, and the MAP actually decreases slightly. There is not reflexive inhibition of the heart, so HR increases dramatically, even more so than it would be with E.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the two major factors involved in CV BP regulation?

A
  1. The wide-spread distribution of alpha and beta receptors in the heart, and blood vessels
  2. The neural and hormonal systems involved in BP regulations.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

The net effect of a given sympathomimetic drug depends on what two things?

A
  1. Its relative receptor selectivity

2. Compensatory baroreceptor reflex mechanisms aimed at restoring BP homeostasis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are the effects of IV E on the BP?

A
  1. Direct vasoconstriction, esp in precapillary resistance vessels of skin, mucosa, and kidney, along with constriction of veins.
  2. Increase in SBP is greater than increase in DBP, so PP increases.
  3. Cardiostimulatory: direct myocardial inotropic and chronotropic effects (increased contractility and HR). This increased HR may be slowed by compensatory vagal stimulation.
  4. However, small doses may decrease BP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Why do small doses of E decrease BP?

A

It has a concentration-dependent effect on the vascular tone due to differential sensitivity of α1 and β2 receptors for E.
At higher doses it causes α1-mediated vasoconstriction and an increase in BP.
At lower/decreasing levels of E, you reach a threshold point where the concentration is not sufficient produce an α-mediated response, but is still sufficient to produce a β2-mediated response, as the vasodilatory β2s have a higher sensitivity. This causes a decrease in BP at small doses.

28
Q

What are the effects of SC epinephrine on BP?

A

The rate at which E gets into circulation is slowed by local vasoconstrictive effect, so smaller concentrations are in the vasculature.
You et a moderate increase in SBP secondary to increased inotropy and CO. DBP is reduced due to low dose β2-predominant vascular effect. So, there is no compensatory baroreceptor reflex is evoked. HR, SV, CO, LV work all increase.
But, If the dose/rate is increased, there may be some vasoconstriction (slight increase in PVR) w/ increased DBP, which evokes the compensatory reflexes.

29
Q

What is the general effect of E on the heart? On what receptors and in what locations does it act?

A

It is a powerful and direct cardiostimulant. It acts on β1’s in myocardium, pacemaker, and conducting tissue (no significant effect on ventricular tissue), esp the SA and AV nodes.

30
Q

What are the specific cardiostimulant effects of E on the heart?

A

Increased HR (shortened systole), CO, and O2 consumption.

31
Q

How does E increase the HR?

A

It facilitates cardiac more rapid cardiac impulse conduction.

  1. Increased relaxation rate of ventricular m
  2. Increased SA node slow depol rate
  3. Activates latent pacemakers
  4. Directly shortens AV node refractory period
32
Q

What are the potential negative consequences of the cardiostimulatory effects of E on the heart?

A

Premature ventricular contractions may occur. leading to various arrhythmias

33
Q

What are the vascular effects of E?

A

It acts primarily on smaller arterioles and precapillary sphincters, substantially redistributing blood flow.Based on the presence of β or alpha receptors in different tissues. It increases skel m and coronary blood flow (β2-mediated). Reduces renal and cutaneous blood flow. Increases pulmonary vascular pressures.

34
Q

What are some adverse consequences of E vascular effects?

A
  1. Increased renal vascular resistance, leading to decreased RBF. This decreased perfusion leads to increased renin release.
  2. Increased pulmonary arterial and venous pressures due to reduced blood flow to other areas. Pulmonary edema can occur.
  3. Increased coronary flow (metabolic dilator effect) may or may not have negative effects.
35
Q

By what routes can you administer E?

A
Primarily IV, occasionaly IM, inhaled
NOT oral (gets metabolized)
36
Q

What are the three main adverse effects of E?

A
  1. Cerebral Hemorrhage, especially with non-specific BBs
  2. Ventricular arrhythmias
  3. Angina
37
Q

What are the therapeutic utilities of E? (3)

A
  1. Emergency relief from hypersensitivity rxns, including anaphylaxis (epipens)
  2. Vasonconstrictor with local anesthetics; topical hemostatic agent
  3. Restoring cardiac rhythm in pt’s with cardiac arrest
38
Q

What is the effect of NE on the TPR, CO, and SV?

A

Increase TPR and SV, but decreases CO or is unchanged

39
Q

Why is CO decreased/unchanged with NE?

A

Vagal opposition of its direct cardioacceleratory action

40
Q

What are the adverse effects of NE?

A

Similar to E, but the increase in BP is more prominent (carefully monitor BP)
Administered IV

41
Q

How is NE administered? What drug is to protect from its negative consequences?

A

IV administration.

Phentolamine can be used to reverse NE-mediated vasoconstriction

42
Q

What is the clinical use of NE?

A

Vasoconstrictor to raise or support BP under certain intensive care conditions

43
Q

What is Dopamine (DA)?

A

Metabolic precursor of E and NE

44
Q

What is the only route DA is given? Why?

A

IV, b/c it has an ultra-short duration of action

45
Q

How can you monitor DA activity? Why?

A

By looking at urine output levels. B/c at very low concentrations it will increase renal perfusion and have natriuretic and diuretic effects.

46
Q

What is meant, when dopamine is described as having a dose-dependent effect?

A

As its dose increases, the receptor that it mediates it effects thru increases.
D1 to Beta1 to alpha

47
Q

What is receptor does dopamine predominantly act on at LOW doses? What are the effects? In what type of patients might you use DA at low doses in?

A

It has predominantly D1 actions.
It vasodilates the RENAL vasculature, increasing renal perfusion, which improves the GFR. So, it is used in patients with diminshed renal perfusion (preserves renal function).

48
Q

What is receptor does dopamine predominantly act on at MODERATE doses? What are the effects?

A

It acts on D1 and β1.
It increases CO (contractility»>HR) and D1-induced vasodilation.
It also causes the release of NE release from sympathetic terminals, which contributes to its effects on the heart.

49
Q

What is receptor does dopamine predominantly act on at HIGH doses? What are the effects?

A

α-agonism predominates.

Increased PVR and renal vasoconstriction

50
Q

What is Dobutamine?

A

β1-agonist
(its actually a racemic mixture of β-agonist, α1-antagonist and α1-agonist, but the α-effects cancel out, so really just a β-agonist)

51
Q

What is the effect of Dobutamine?

A

It increases CO and SV, WITHOUT marked effect on HR.
It increases myocardial contractility and reduces LV filling pressures.
It increases urinary output secondary to increased CO.

52
Q

How is Dobutamine administered? Why?

A

Infusion b/c ultrashort half-life

53
Q

What is the clinical use of Dobutamine?

A

For short-term treatment of cardiac decompensation, such as after cardiac surgery, CHF, or acute MI.

54
Q

Thru what receptors does Isoproterenol act? What are its effects?

A

β1 and β2 (NOT alphas)

It increases CO (+inotropic and chronotropic effects) and decreased diastolic BP (decreased PVR)

55
Q

How is isoproterenol administered?

A

parenteral or by aerosol

56
Q

What are the adverse effects of isoproterenol?

A

Palpitations, tachycardia, headache, and flushing are common

57
Q

What is the clinical use of Isoproterenol?

A

Used in emergencies to stimulate HR in patients with bradycardia or heart block, particular in anticipation of inserting an artificial cardiac pacemaker, or in pt;s with the ventricular arrhythmia torsades de pointes

58
Q

On what receptors does phenylephrine act?

A

It is a potent direct-acting α-agonist with virtually no B activity

59
Q

What are the effects of Rx with phenylephrine?

A

Systemic arterial vasoconstriction→increase SBP and DBP

There is a reflex decrease in HR and CO

60
Q

What is the clinical use of phenylephrine?

A

Control of hypotension during a procedure for spinal epidural anesthesia, as some patients may respond with a significant drop in BP

61
Q

What are the adverse effects of phenylephrine?

A

Angina, anxiety, hallucinations or psychosis (rare), hypertension, excitability, dizziness, insomnia, pallor, and restlessness
These are more common with parenteral administration

62
Q

What receptors does ephedrine act on? What is unique about it?

A

It is a MIXED-ACTING sympathomimetic.
It is a direct agonist of both α and β receptors.
It also indirectly enhances the release of NE from sympathetic neurons.

63
Q

How ephedrine administered? How is it eliminated?

A

Orally; eliminated largely unchanged in the urine.

64
Q

What is the clinical use of ephedrine?

A

Similar to phenylephrine

Used for hypotension and hypotension of analgesia

65
Q

What are the effects of ephedrine Rx?

A

Increase HR and CO; variable increase in PVR; net increase in BP

66
Q

What are the adverse effects of ephedrine?

A
  1. Increased workload→angina
  2. Myocardial stimulation→ventricular dysfunction, palpitations, and s-TACH
  3. Fatal Arrhythmias, including V-fib